Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 1 day ago • ZTS
Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors
Seeking Alpha • 1 day ago • ZTS
Zoetis: Why I'm Doubling Down On My Worst 2025 Pick
Benzinga • 5 days ago • ZTS
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide
Seeking Alpha • 5 days ago • ZTS
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zacks Investment Research • 5 days ago • ZTS
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.